Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MHC class I proteins play a central role in adaptive immunity by presenting intracellularly derived antigens for surveillance by cytotoxic T lymphocytes while also modulating innate responses via interactions with natural killer cells. Their structure—a heavy chain paired with β2-microglobulin—enables selective binding and display of short peptides at the cell surface for immune recognition. High genetic diversity ensures broad population-level protection against pathogens but complicates tissue transplantation due to alloimmune responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major Histocompatibility Complex Class I Protein (MHC Class I).